JP Stock MarketDetailed Quotes

4569 Kyorin Pharmaceutical

Watchlist
  • 1657
  • +3+0.18%
20min DelayMarket Closed Jun 7 15:00 JST
95.19BMarket Cap17.87P/E (Static)

About Kyorin Pharmaceutical Company

Kyorin Pharmaceutical Co Ltd is engaged in manufacturing and sale of pharmaceutical products. The company manages its business in two reportable segments namely Pharmaceutical Business and the Consumer Healthcare (Skincare) Business. The Pharmaceutical business focuses on producing and selling ethical drugs, generic drugs and over-the-counter drugs. The Consumer Healthcare (Skincare) Business mainly sells and purchases skincare products. The company's products include Kipres, for treating bronchial asthma and allergic rhinitis; Mucodyne, a mucoregulant; Pentasa, for treating ulcerative colitis and Crohn's disease; and Uritos, for treating overactive bladder. Majority of the company's revenue comes from domestic sales.

Company Profile

Symbol4569
Company NameKyorin Pharmaceutical
Founded1958-10-31
MarketTSE Prime
Employees2156
Fiscal Year Ends03-31
Address6, Kanda Surugadai 4-chome Chiyoda-ku
Zip Code101-8311
Phone03-3525-4700

Company Executives

  • Name
  • Position
  • Salary
  • Yutaka Ogihara
  • Director, President and Chief Executive Officer
  • --
  • Michiro Onota
  • Director and Chief Marketing Officer
  • --
  • Minoru Hogawa
  • Chairman of the Board
  • --
  • Hiromi Watanabe
  • Independent Director
  • --
  • Noriyuki Shikanai
  • Independent Director
  • --
  • Ken Shigematsu
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
JP
Overall
Symbol
Latest Price
%Chg